AQST News and Press, Aquestive Therapeutics Inc.

Thomas A. Zalewski, a Partner at Day Pitney LLP, appointed Chief Legal Officer and Chief Compliance Officer effective April 2, 2026 Lori J. Braender to remain in a non-executive role as Corporate Secretary after nearly eight years as Chief Legal Officer, Chief Compliance Officer and Corporate ...

2026-03-13 05:38:55 ET The CRL and the Nature of the Deficiencies When I wrote about Aquestive Therapeutics ( AQST ) on January 12, 2026, the FDA had just informed the company that it had identified “deficiencies that preclude discussion of labeling and post-marke...

AQST Lawsuit Alleges Analyst Slashed Price Target - AQUESTIVE THERAPEUTICS, INC. Investors Face Losses Following Analyst Slashed Price Target: SueWallSt PR Newswire Wall Street Reassessment: Analyst Opinion Evolution on AQST NEW YORK , March 12, 2026 /PRNewswire/ -- On January...

2026-03-11 02:46:47 ET Article Thesis I wrote about Aquestive Therapeutics, Inc. ( AQST ) at the beginning of May last year, and I saw it as a “Buy” with the stock around $3. My thesis is underpinned by Anaphylm , their epinephrine-based sublingual film, wh...

Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Aquestive Therapeutics, Inc. (NASDAQ: AQST) between June 16, 2025 and January 8, 2026. Aquestive describes itself as a “pharmaceutical company committed to advancing...

WARREN, N.J., March 09, 2026 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technolo...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Aquestive Therapeutics To Contact Him Directly To Discuss Their Options If you suffered significant losses in Aquestive Therapeutics s...

2026-03-05 13:16:33 ET More on Aquestive Therapeutics Aquestive Therapeutics, Inc. (AQST) Q4 2025 Earnings Call Transcript Aquestive Therapeutics, Inc. 2025 Q4 - Results - Earnings Call Presentation Aquestive Therapeutics: Biology Validated, Packaging Pending - A For...

2026-03-05 13:15:55 ET Aquestive Therapeutics, Inc. (AQST) Q4 2025 Earnings Call March 5, 2026 8:00 AM EST... Read the full article on Seeking Alpha For further details see: Aquestive Therapeutics, Inc. (AQST) Q4 2025 Earnings Call Transcript

2026-03-05 09:43:03 ET Image source: The Motley Fool. March 5, 2026 at 8:00 a.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading